Management of kidney cancer: canadian kidney cancer forum consensus update 2011.
作者信息
Jewett Mas, Finelli A, Kollmannsberger C, Wood L, Legere L, Basiuk J, Canil C, Heng D, Reaume N, Tanguay S, Atkins M, Bjarnason G, Dancey J, Evans M, Fleshner N, Haider M, Kapoor A, Uzzo R, Maskens D, Soulieres D, Yousef G, Basappa N, Bendali N, Black P, Blais N, Cagiannos I, Care M, Chow R, Chung H, Czaykowski P, Derosa D, Durrant K, Ellard S, Farquharson G, Filion-Brulotte C, Gingerich J, Godbout L, Grant R, Hamilton W, Kassouf W, Kurban G, Lane K, Lattouf Jb, Lau D, Leveridge M, McCarthy J, Moore R, North S, O'brien P, Pituskin E, Racine P, Rendon R, So A, Sridhar S, Stubbs K, Su Z, Taylor L, Udall T, Venner P, Vogel W, Yap S, Yau P, Cooper M, Giroux N, Miron D, Mosher D, Ross K, Willacy J
出版信息
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
Abstract
摘要
相似文献
1
Management of kidney cancer: canadian kidney cancer forum consensus update 2011.
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
2
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536.
3
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
4
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
5
Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.
Can Urol Assoc J. 2008 Jun;2(3):175-82.
6
Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.
Can Urol Assoc J. 2014 May;8(5-6):E398-412. doi: 10.5489/cuaj.1894.
7
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5.
8
Canadian Forum on Combined Organ Transplantation.
Transplantation. 2016 Jun;100(6):1339-48. doi: 10.1097/TP.0000000000000963.
9
Report of the 2003 pan-Canadian forum on cervical cancer prevention and control.
J Obstet Gynaecol Can. 2004 Nov;26(11):1004-28. doi: 10.1016/s1701-2163(16)30423-6.
10
Canadian Cardiovascular Society Clinical Practice Update on the Assessment and Management of Syncope.
Can J Cardiol. 2020 Aug;36(8):1167-1177. doi: 10.1016/j.cjca.2019.12.023. Epub 2020 Jul 2.
引用本文的文献
1
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
J Cancer Res Clin Oncol. 2022 Jan;148(1):215-224. doi: 10.1007/s00432-021-03688-2. Epub 2021 Jun 9.
2
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.
Can Urol Assoc J. 2021 Apr;15(4):84-97. doi: 10.5489/cuaj.7245.
3
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.
Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256.
4
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.
J Urol. 2018 Aug;200(2):275-282. doi: 10.1016/j.juro.2018.02.3087. Epub 2018 Mar 1.
5
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
6
Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.
CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.
7
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
8
Canadian guidelines for SRMs: How Canadian are they?
Can Urol Assoc J. 2015 May-Jun;9(5-6):163-213. doi: 10.5489/cuaj.3040.
9
Canadian guidelines for the management of small renal masses (SRM).
Can Urol Assoc J. 2015 May-Jun;9(5-6):160-3. doi: 10.5489/cuaj.2969.
10
Landmarks in the diagnosis and treatment of renal cell carcinoma.
Nat Rev Urol. 2014 Sep;11(9):517-25. doi: 10.1038/nrurol.2014.194. Epub 2014 Aug 12.
本文引用的文献
1
Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.
Eur Urol. 2011 Sep;60(3):578-84. doi: 10.1016/j.eururo.2011.06.021. Epub 2011 Jun 24.
2
ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
Eur Urol. 2011 Oct;60(4):684-90. doi: 10.1016/j.eururo.2011.06.017. Epub 2011 Jun 24.
3
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1.
4
Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22.
5
Chronic kidney disease before and after partial nephrectomy.
J Urol. 2011 Jan;185(1):43-8. doi: 10.1016/j.juro.2010.09.019. Epub 2010 Nov 12.
6
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.
J Urol. 2011 Jan;185(1):60-6. doi: 10.1016/j.juro.2010.09.012. Epub 2010 Nov 12.
7
Impact of nephron sparing on kidney function and non-oncologic mortality.
Urol Oncol. 2010 Sep-Oct;28(5):568-74. doi: 10.1016/j.urolonc.2010.03.018.
8
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.
Radiology. 2010 Sep;256(3):836-46. doi: 10.1148/radiol.10092013.
9
Contemporary management of renal tumors with venous tumor thrombus.
J Urol. 2010 Sep;184(3):833-41; quiz 1235. doi: 10.1016/j.juro.2010.04.071.
10
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.
Cancer. 2010 Sep 15;116(18):4256-65. doi: 10.1002/cncr.25219.
Zotero 插件